Large differences in prevalence of Pfcrt and Pfmdr1 mutations between Mwanza, Tanzania and Iganga, Uganda-a reflection of differences in policies regarding withdrawal of chloroquine?

@article{Kamugisha2012LargeDI,
  title={Large differences in prevalence of Pfcrt and Pfmdr1 mutations between Mwanza, Tanzania and Iganga, Uganda-a reflection of differences in policies regarding withdrawal of chloroquine?},
  author={Erasmus Kamugisha and Ioana Bujila and Mona Lahdo and Samtou Pello-Esso and Mercy Maria Minde and Gilbert W. Kongola and Halima Naiwumbwe and Steven M. Kiwuwa and Mark Kaddumukasa and Fred Kironde and G{\"o}te Swedberg},
  journal={Acta tropica},
  year={2012},
  volume={121 2},
  pages={148-51}
}
BACKGROUND Malaria is still a major public health problem in the world and sub-Saharan Africa is one of the most affected areas. Efforts to control malaria are highly affected by drug resistance to commonly used antimalarials. The introduction of artemisinin based combination therapy (ACT) as a first line drug seems to be a major step in treatment of uncomplicated malaria, though search for drugs to combine with artemisinins still continues. There have been reports on increased prevalence of… CONTINUE READING